Reilly Financial Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Reilly Financial Advisors’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$7K	Hold	220	–	–	﹤0.01%	782
2021 Q3	$7K	Hold	220	–	–	﹤0.01%	707
2021 Q2	$9K	Hold	220	–	–	﹤0.01%	718
2021 Q1	$10K	Hold	220	–	–	﹤0.01%	702
2020 Q4	$12K	Sell	220 -259	-54%	-$12.9K	﹤0.01%	591
2020 Q3	$23K	Buy	479 +259	+118%	+$14.4K	﹤0.01%	427
2020 Q2	$13K	Buy	220 +50	+29%	+$2.78K	﹤0.01%	525
2020 Q1	$8K	Hold	170	–	–	﹤0.01%	588
2019 Q4	$10K	Sell	170 -150	-47%	-$8.94K	﹤0.01%	623
2019 Q3	$19K	Hold	320	–	–	﹤0.01%	521
2019 Q2	$21K	Hold	320	–	–	﹤0.01%	519
2019 Q1	$26K	Hold	320	–	–	﹤0.01%	467
2018 Q4	$17K	Sell	320 -200	-38%	-$10.2K	﹤0.01%	528
2018 Q3	$27K	Hold	520	–	–	﹤0.01%	481
2018 Q2	$22K	Hold	520	–	–	﹤0.01%	472
2018 Q1	$23K	Hold	520	–	–	﹤0.01%	452
2017 Q4	$26K	Hold	520	–	–	﹤0.01%	449
2017 Q3	$26K	Hold	520	–	–	﹤0.01%	436
2017 Q2	$26K	Hold	520	–	–	﹤0.01%	440
2017 Q1	$21K	Hold	520	–	–	﹤0.01%	468
2016 Q4	$25K	Hold	520	–	–	﹤0.01%	408
2016 Q3	$19K	Hold	520	–	–	﹤0.01%	417
2016 Q2	$12K	Buy	+520	New	+$16.8K	﹤0.01%	468
2015 Q4	–	Sell	-520	Closed	-$28.1K	–	1292
2015 Q3	$21K	Sell	520 -25	-5%	-$1.29K	﹤0.01%	590
2015 Q2	$31K	Buy	545 +25	+5%	+$1.59K	0.01%	551
2015 Q1	$33K	Sell	520 -100	-16%	-$6.79K	0.01%	518
2014 Q4	$38K	Hold	620	–	–	0.01%	300
2014 Q3	$24K	Buy	620 +520	+520%	+$18.4K	0.01%	363
2014 Q2	$4K	Buy	+100	New	+$3.15K	﹤0.01%	706
2014 Q1	–	Sell	-145	Closed	-$6K	–	824
2013 Q4	$6K	Buy	+145	New	+$5.17K	﹤0.01%	636

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Reilly Financial Advisors's IONS Position: Q4 2021 in Review

Reilly Financial Advisors held its Ionis Pharmaceuticals (IONS) position steady in Q4 2021 at 220 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #782.

Reilly Financial Advisors first reported a position in IONS in Q4 2013 and has held it in 30 quarters since. The position peaked at $38K in Q4 2014. 341 funds tracked by Wall St. Rank hold IONS as of Q4 2021.

Reilly Financial Advisors held 220 shares of Ionis Pharmaceuticals worth $7K as of Q4 2021.
Reilly Financial Advisors left its Ionis Pharmaceuticals share count unchanged in Q4 2021.
Ionis Pharmaceuticals made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #782 holding.
Reilly Financial Advisors first reported a position in Ionis Pharmaceuticals in Q4 2013 and has held it in 30 quarters since.
Reilly Financial Advisors's Ionis Pharmaceuticals position peaked at $38K in Q4 2014.
341 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.